Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Lab Autom. 2014 Dec;19(6):511-6. doi: 10.1177/2211068214538263. Epub 2014 Jun 5.

Nanomedicine for global health.

Author information

  • 1Division of Oral Biology and Medicine, UCLA School of Dentistry, Los Angeles, CA, USA.
  • 2Department of Bioengineering, UCLA School of Engineering and Applied Science, Los Angeles, CA, USA.
  • 3Cancer Science Institute of Singapore, Yong Loo Lin School of Medicine, National University of Singapore, Singapore Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • 4Division of Oral Biology and Medicine, UCLA School of Dentistry, Los Angeles, CA, USA Department of Bioengineering, UCLA School of Engineering and Applied Science, Los Angeles, CA, USA Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA, USA California NanoSystems Institute, UCLA, Los Angeles, CA, USA csikce@nus.edu.sg dean.ho@ucla.edu.

Abstract

Despite modern advances, a broad range of disorders such as cancer and infectious diseases continually afflict the global population. Novel therapeutics are continuously being explored to address these challenges. Therefore, scalable, effective, and safe therapies that are readily accessible to third-world countries are of major interest. In this article, we discuss the potential advantages that the nanomedicine field may harness toward successful implementation against some of the major diseases of our generation.

© 2014 Society for Laboratory Automation and Screening.

KEYWORDS:

HIV/AIDS; cancer; drug delivery; global health; nanomedicine

PMID:
24902713
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk